MedTrace Logo

Improved Outcomes Associated With Inositol Dietary Supplementation in Women With Gestational Diabetes Mellitus

NCT01342874 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2012-02-09

No results posted yet for this study

Summary

Objective: Insulin resistance during normal pregnancy and in gestational diabetes mellitus (GDM) are unknown. New criteria are based on fasting glucose levels since the beginning of pregnancy. Inositol, a putative second messenger of insulin, correlates with the degree of insulin resistance. Dietary supplementation of inositol improves insulin resistance in patients with GDM.

Conditions

  • Gestational Diabetes Mellitus

Interventions

DIETARY_SUPPLEMENT

Inositol

inositol exposure in early GDM

Sponsors & Collaborators

  • G. d'Annunzio University

    lead OTHER

Principal Investigators

  • Claudio Celentano, MD · ObGyn Dept

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-04-30
Completion
2011-08-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01342874 on ClinicalTrials.gov